JYNT News & Events

Reports Q1 revenue $14.82M, consensus $14.5M. "During the first quarter of 2026, we continued to build a more efficient and profitable platform, advancing our refranchising efforts, optimizing our clinic portfolio, and tightening our operating structure across the system," said President and Chief Executive Officer of The Joint Corp., Sanjiv Razdan. "In April, we entered into an agreement for the sale of 45 of our company-owned or managed clinics, effectively completing our Joint 2.0 refranchising initiative, with fewer than 1% of our remaining clinic portfolio being company-owned or managed. At the same time, we remain active with our capital allocation priorities with continued share repurchases, as well as the recent completion of three regional developer buybacks that further optimize our portfolio economics."

The company said, "New franchised clinic openings, excluding the impact of refranchised clinics, are expected to be in the range of 30 to 35. The Company is working with franchise owners to optimize the performance of the existing franchised clinic base. This may include closing underperforming clinics this year, which will result in the overall clinic count at 2026 year end being lower than 2025 year end."

Joint Corp. announced that it has signed an asset purchase agreement effective on April 20 for the sale of 45 corporate managed clinics in Southern California to Elite Chiro Group for approximately $2.3M. Pursuant to the APA, Elite Chiro Group will assume business operations of 32 of those clinics April 27 through a management service agreement until lease assignments are completed to permit the clinics' ownership transfer, and will assume ownership of the remaining 13 corporate-managed clinics. Upon completion, this transaction, together with two previously announced refranchising agreements pending closing, will reduce the company's corporate managed clinics to just three out of 960 locations in its total clinic portfolio.